← Eichor
Condition: Arid1A Gene Mutation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Arid1A Gene Mutation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
Phase 2 · 2 location(s) · Panagiotis Konstantinopoulos, MD, PhD · NCT06518564Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Phase 2 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06617923JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · Jacobio Pharmaceuticals Co., Ltd. · NCT05490472
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.